The proline catabolic enzyme Δ 1 -pyrroline-5-carboxylate dehydrogenase (ALDH4A1) catalyzes the NAD + -dependent oxidation of γ-glutamate semialdehyde to Lglutamate. In Saccharomyces cerevisiae, ALDH4A1 is encoded by the PUT2 gene and known as Put2p. Here we report the steady-state kinetic parameters of the purified recombinant enzyme, two crystal structures of Put2p, and the determination of the oligomeric state and quaternary structure from smallangle X-ray scattering and sedimentation velocity. Using Δ 1 -pyrroline-5-carboxylate as the substrate, catalytic parameters k cat and K m were determined to be 1.5 s −1 and 104 μM, respectively, with a catalytic efficiency of 14000 M −1 s −1 . Although Put2p exhibits the expected aldehyde dehydrogenase superfamily fold, a large portion of the active site is disordered in the crystal structure. Electron density for the 23-residue aldehyde substrate-binding loop is absent, implying substantial conformational flexibility in solution. We furthermore report a new crystal form of human ALDH4A1 (42% identical to Put2p) that also shows disorder in this loop. The crystal structures provide evidence of multiple active site conformations in the substrate-free form of the enzyme, which is consistent with a conformational selection mechanism of substrate binding. We also show that Put2p forms a trimer-of-dimers hexamer in solution. This result is unexpected because human ALDH4A1 is dimeric, whereas some bacterial ALDH4A1s are hexameric. Thus, global sequence identity and domain of life are poor predictors of the oligomeric states of ALDH4A1. Mutation of a single Trp residue that forms knob-in-hole interactions across the dimer−dimer interface abrogates hexamer formation, suggesting that this residue is the center of a protein−protein association hot spot.
1
pyrroline-5-carboxylate as the substrate, catalytic parameters k cat and K m were determined to be 1.5 s −1 and 104 μM, respectively, with a catalytic efficiency of 14000 M −1 s −1 . Although Put2p exhibits the expected aldehyde dehydrogenase superfamily fold, a large portion of the active site is disordered in the crystal structure. Electron density for the 23-residue aldehyde substrate-binding loop is absent, implying substantial conformational flexibility in solution. We furthermore report a new crystal form of human ALDH4A1 (42% identical to Put2p) that also shows disorder in this loop. The crystal structures provide evidence of multiple active site conformations in the substrate-free form of the enzyme, which is consistent with a conformational selection mechanism of substrate binding. We also show that Put2p forms a trimer-of-dimers hexamer in solution. This result is unexpected because human ALDH4A1 is dimeric, whereas some bacterial ALDH4A1s are hexameric. Thus, global sequence identity and domain of life are poor predictors of the oligomeric states of ALDH4A1. Mutation of a single Trp residue that forms knob-in-hole interactions across the dimer−dimer interface abrogates hexamer formation, suggesting that this residue is the center of a protein−protein association hot spot.
T he mitochondrial enzymes Put1p and Put2p catalyze proline catabolism in Saccharomyces cerevisiae ( Figure 1 ). Put1p is a flavin-dependent dehydrogenase that catalyzes the oxidation of L-proline to Δ 1 -pyrroline-5-carboxylate (P5C) and couples proline oxidation to reduction of ubiquinone. 1 Put2p is a P5C dehydrogenase (P5CDH, EC 1.2.1.88, formerly EC 1.5.1.12) and is also known as ALDH4A1 in reference to its membership in family 4 of the aldehyde dehydrogenase (ALDH) superfamily. 2 Put2p catalyzes the NAD + -dependent oxidation of γ-glutamate semialdehyde (GSA, the hydrolysis product of P5C) to L-glutamate. In total, the proline catabolic pathway catalyzes a four-electron oxidation of proline.
Several studies have shown that proline is important in various organisms for stress protection. 3 The accumulation of proline in yeast leads to improved freeze tolerance. 4 In contrast to that of proline, the accumulation of P5C is associated with toxicity effects and induced cell death in yeast. 5, 6 Coordinated expression of PUT1 and PUT2 is important for avoiding buildup of P5C. The PUT1 and PUT2 genes are upregulated by proline under nitrogen limiting conditions and, together with glutamate dehydrogenase, allow yeast to utilize proline as a nitrogen source. 7 The mechanism of P5C toxicity involves inhibition of mitochondrial respiration and an increased level of production of reactive oxygen species. 5 Interestingly, an Nacetyltransferase enzyme known as Mpr1 acetylates P5C, thereby decreasing its level of accumulation and weakening its harmful effects in yeast. 8 Mammalian P5CDHs have been characterized biochemically. Early studies of the human (HsP5CDH) and rat enzymes established the order of substrate binding and product release, as well as substrate preferences. 9−11 More recent work on HsP5CDH and mouse P5CDH (MmP5CDH) provided additional details about the kinetic mechanism and the molecular basis of type II hyperprolinemia, 12 a metabolic disorder caused by a defect in ALDH4A1 function.
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The three-dimensional structures of P5CDHs have been studied intensely. Tahirov's group reported the first P5CDH structure using the enzyme from Thermus thermophilus (TtP5CDH). 16, 17 We subsequently determined the structures of HsP5CDH and MmP5CDH, 12, 18 and the New York Structural Genomics Research Consortium has deposited structures of two Bacillus P5CDHs in the Protein Data Bank (PDB) (entries 3QAN and 3RJL). Collectively, the structures confirmed P5CDH as a member of the ALDH superfamily, contributed additional information about the catalytic mechanism, and provided insight into the structural basis of cofactor and semialdehyde selectivity. We also determined the solution oligomeric states and quaternary structures of several P5CDHs. 19 The human, mouse, and Bacillus enzymes are dimeric in solution, whereas TtP5CDH and Deinococcus radiodurans P5CDH (DrP5CDH) form trimer-of-dimers hexamers in solution. Thus, the protein fold, but not the oligomeric state, is conserved within the ALDH4A1 subfamily.
Although the yeast PUT genes were identified more than 30 years ago, the Put1p and Put2p enzymes have remained relatively understudied. Wanduragala et al. reported the purification and characterization of Put1p in 2010, 1 but analogous studies of Put2p have not appeared in the literature. We therefore have created a recombinant bacterial expression system for Put2p, measured the steady-state kinetic parameters of the purified enzyme, determined the crystal structure, and deduced the oligomeric state and quaternary structure in solution from small-angle X-ray scattering (SAXS).
■ EXPERIMENTAL PROCEDURES
Subcloning and Mutagenesis. The PUT2 gene was obtained from M. Brandriss of the Rutgers New Jersey Medical School and subcloned into vectors pET14b using NdeI and XhoI and pKA8H between NdeI and BamHI restriction sites, resulting in pET14b-PUT2 and pKA8H-PUT2 constructs. DNA encoding residues 23−575, which lacks the N-terminal mitochondrial targeting peptide, 20 was amplified from pKA8H using AAACATATGAAGCCCCCCAAGCACATAAG as the forward primer and the T7 terminator as the reverse primer. The resulting fragment was subcloned into pKA8H using NdeI and BamHI to give the pKA8H-PUT2Δ22 construct. The expressed protein has an N-terminal His 8 tag and tobacco etch virus protease cleavage site.
The W193A mutant of Put2p was created from pKA8H-PUT2Δ22 with the QuikChange II site-directed mutagenesis kit (Agilent) using the forward primer (5′-GGTACAATCTA-CCGTTTGCTGACAGATCTGC-3′) and reverse primer (5′-GCAGATCTGTCAGCAAACGGTAGATTGTACC-3′). The mutation was confirmed using DNA sequencing.
Expression and Purification of Put2p. Put2p and Put2p mutant W193A were expressed in Bl21(DE3)pLysS cells. Cells were grown at 37°C and 250 rpm until the OD 600 reached 0.6 and induced with 0.5 mM IPTG for 8 h at 22°C and 200 rpm. The cells were harvested by centrifugation at 3500 rpm for 30 min and resuspended in 20 mM HEPES, 60 mM NaCl, and 5% glycerol (pH 8.0). Cells were quick frozen in liquid nitrogen and stored at −80°C until they were further purified.
Thawed cells were broken by sonication and centrifuged at 16500 rpm for 1 h. The supernatant was applied to a HisTrap HP column that had been charged with Ni 2+ and equilibrated with 20 mM HEPES, 300 mM NaCl, and 5% glycerol (pH 8.0). The column was washed with equilibration buffer supplemented with 30 mM imidazole, and the enzyme was eluted with 300 mM imidazole. Fractions containing Put2p were pooled, dialyzed into 50 mM Tris, 0.5 mM EDTA, 0.5 mM tris(hydroxypropyl)phosphine (THP), and 5% glycerol (pH 8.0), and loaded onto a HiTrap Q anion exchange column. Put2p was eluted with a linear gradient of NaCl from 0 to 1 M. Fractions were analyzed via sodium dodecyl sulfate−polyacrylamide gel electrophoresis, pooled, and dialyzed into 50 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol (pH 8.0).
Crystallization of Put2p. Crystallization trials were performed in sitting drops at 20°C using drops formed by mixing 1 μL each of the enzyme and reservoir solutions. Crystal screening using commercially available kits (Hampton Research) was used to identify promising crystallization conditions.
Put2p expressed from pKA8H-PUT2Δ22, including the Nterminal His tag, was used for crystallization. Optimized crystals were grown using 8 mg/mL enzyme and a reservoir containing Expression, Purification, and Crystallization of TagFree HsP5CDH. HsP5CDH residues 18−563 with an Nterminal His tag were expressed and purified as described previously. 12 The His tag was removed with thrombin as follows. The purified protein was dialyzed into thrombin cleavage buffer [20 mM Tris, 150 mM NaCl, 2.5 mM CaCl 2 , and 5% glycerol (pH 8.0)] and incubated with thrombin (1 unit of thrombin per 4 mg of HsP5CDH) for 1 day at 4°C. Thrombin was removed using a HiTrap Benzamidine FF affinity column. The cleaved His tag and residual unprocessed HsP5CDH were removed by passing the sample through a Ni 2+ -charged HisTrap HP column. The tag-free enzyme was collected in the flow-through, dialyzed into 50 mM Tris, 50 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol (pH 8.0), and concentrated to 6 mg/mL for crystallization trials.
Crystal screening revealed a promising crystal form grown in PEG 3350 and MgCl 2 . Optimized crystals were grown using a reservoir of 20−25% (w/v) PEG 3350, 0. 21 This form differs from the hexagonal form of His-tagged HsP5CDH reported previously.
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X-ray Diffraction Data Collection, Phasing, and Refinement. Crystals were analyzed at NE-CAT beamlines 24-ID-C and 24-ID-E at the Advanced Photon Source using a Quantum 315 detector ( Table 1 ). The Put2p data set was obtained at beamline 24-ID-C and consisted of 105 frames collected with an oscillation width of 1°, a detector distance of 225 mm, and an exposure time of 1.0 s/frame at 7% transmission. The data were processed to 1.95 Å resolution using HKL2000. 22 Data from Put2p−NAD + crystals were collected at beamline 24-ID-E and processed with XDS. 23 The 2.2 Å resolution data set consisted of 70 frames collected with an oscillation width of 1°, a detector distance of 200 mm, and an exposure time of 1.0 s/frame at 55% transmission. Data from HsP5CDH crystals were collected at beamline 24-ID-C. The data set used for refinement consisted of 180 frames collected with an oscillation width of 1°, a detector distance of 250 mm, and an exposure time of 1.0 s/frame at 4% transmission. The data were processed to 1.95 Å resolution using HKL2000.
The phase problem was solved using molecular replacement as implemented in MOLREP. 24 The search model for Put2p was derived from a 1.3 Å resolution structure of mouse P5CDH (PDB entry 3V9J, 12 43% identical sequence over 543 residues). The search model for HsP5CDH was obtained from a 2.5 Å resolution structure of HsP5CDH (PDB entry 3V9G 12 ). The models from molecular replacement were used as the starting points for several rounds of model building with COOT 25 and refinement with PHENIX. 26 The refined Put2p structure was used as the starting point for refinement of the structure of the Put2p−NAD + complex. Small-Angle X-ray Scattering of Put2p. In preparation for SAXS studies, wild-type Put2p was purified in a manner similar to that used for crystallization except for the following modifications. After the first Ni 2+ affinity step, tobacco etch virus protease was added to the pooled fractions and incubated at 28°C for 2 h. The protein was then dialyzed overnight against 20 mM HEPES, 100 mM NaCl, and 5% glycerol (pH 8.2). The protein was then injected onto the Ni 2+ affinity column and eluted at 30 mM imidazole. The fractions were collected, pooled, and dialyzed overnight against 50 mM Tris (pH 7.5), 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol. The protein was further purified using anion exchange (HiTrap Q) and dialyzed into 50 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol (pH 8.0). Finally, size exclusion chromatography was performed using a Superdex 200 column that had been equilibrated in dialysis buffer. Protein appearing in the void volume was discarded, while protein that eluted as a single peak that was clearly separated from the void volume was collected. The pooled fractions had a concentration of approximately 3 mg/mL (BCA method). The protein was then concentrated using a Millipore centrifugal unit to 7 mg/ mL. The flow-through of the centrifugal unit was reserved as the reference for SAXS. Put2p mutant W193A was prepared similarly, except that the final buffer had a somewhat lower pH and a higher ionic strength [50 mM Tris, 300 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol (pH 7.5)].
SAXS experiments were performed at SIBYLS beamline 12.3.1 of the Advanced Light Source through the mail-in program. 27, 28 For each sample, scattering intensities were measured at three nominal protein concentrations. Data were collected for each protein concentration at exposure times of 0.5, 1.0, 3.0, and 6.0 s. The scattering curves collected from the protein samples were corrected for background scattering using intensity data collected from the reference buffer.
The SAXS data were analyzed as follows. Composite scattering curves were generated with PRIMUS 29 by scaling and merging the background-corrected low-q region data from the 0.5 s exposure (wild type) or 0.1 s exposure (W193A) with the high-q region data from the 3.0 s exposure (wild type) or 6.0 s exposure (W193A). PRIMUS was also used to perform Guinier analysis. FoXS was used to calculate theoretical scattering profiles from atomic models. 30 GNOM was used to calculate pair distribution functions. 31 The SASTBX server 32 was used for shape reconstruction calculations. Analytical Ultracentrifugation. W193A (His tag removed) was analyzed by sedimentation velocity using a Beckman XL-I analytical ultracentrifuge. Following dialysis to equilibrium against the buffer [50 mM Tris, 300 mM NaCl, 0.5 mM EDTA, 0.5 mM THP, and 5% glycerol (pH 7.5)], the protein solution was diluted with dialysis buffer to yield an absorbance (at 280 nm) of 0.95 in a 1.0 cm path length cuvette. A 400 μL aliquot was loaded into the sample compartment of a double-sector cell, assembled with a 1.2 cm charcoal-Epon centerpiece and quartz windows. A slightly larger volume (430 μL) of dialysis buffer was placed in the reference compartment. The sample cell was placed in the rotor and allowed to equilibrate to 20°C in the rotor chamber for 2 h under vacuum, prior to beginning the experiment. The sample was then sedimented at 30000 rpm, acquiring data at 4 min intervals, until a total of 170 scans had been collected. The resulting data set was analyzed with SEDFIT version 9.4, 33 using the continuous c(s) and continuous c(M) distribution models, allowing the frictional ratio to float.
Steady-State Kinetics. P5CDH activity was measured with Put2p expressed from pET14b-PUT2, including the N-terminal six-His tag. Put2p activity was followed by monitoring the formation of NADH at 20°C as described previously for human P5CDH. 12 The assay buffer contained 50 mM potassium phosphate (pH 7.5) and 25 mM NaCl. The Put2p concentration was 0.4 μM (25.6 μg/mL), and the NAD + concentration was held constant at 0.2 mM. Initial velocity data were collected using L-P5C concentrations from 1 to 300 μM. Initial velocity data were fit to the Michaelis−Menten equation to estimate K m and k cat .
■ RESULTS Steady-State Kinetics Measurements. Brandriss and coworkers previously measured Put2p enzymatic activity in cellular and mitochondrial extracts to verify the identity of the enzyme and determine the subcellular location. 34−36 To the best of our knowledge, the catalytic properties of the purified enzyme have not been studied. We therefore performed steadystate kinetic measurements of recombinant Put2p. Kinetic parameters for Put2p were as follows: K m = 104 ± 4 μM L-P5C, and k cat = 1.5 ± 0.3 s ).
Protomer Structure of Put2p. The 1.95 Å resolution crystal structure of Put2p was determined (Table 1) . Put2p exhibits the expected ALDH fold, which consists of three domains (Figure 2A (residues 43−181, 200−319, and 536−553). The catalytic domain (residues 320−535) interrupts the NAD + -binding domain and exhibits an open α/β fold featuring a twisted seven-stranded β-sheet with all but one strand in parallel. This domain furnishes the essential cysteine nucleophile (Cys351), which is situated at the interface of the NAD + -binding and catalytic domains. The third domain is a bipartite β substructure consisting of residues 182−199 and 554−565 that protrudes from the NAD + -binding domain. This domain is involved in oligomerization. As with other ALDHs, Put2p forms a dimer in which the oligomerization domain of one protomer engages the catalytic domain of the other protomer ( Figure 2B ). The asymmetric unit contains one dimer. As described below, three Put2p dimers assemble into a hexamer in solution.
The most conspicuous feature of the Put2p structure is that which is unseen. ALDHs have an ∼25-residue peptide that connects the last strand of the catalytic domain to the second piece of the oligomerization domain. This section corresponds to residues 523−547 of Put2p. Electron density for these residues is very weak, implying substantial conformational disorder ( Figure 3A ). The lack of density for this part of the protein gives the impression of a large void running lengthwise through the middle of the dimer ( Figure 3A) .
The omission of residues 524−546 from the Put2p model is notable because this region of ALDHs anchors the aldehyde substrate in the active site ( Figure 3B ). In other P5CDHs (and ALDHs in general), the 25-residue aldehyde-binding loop folds into a two-stranded antiparallel β-sheet that forms the floor of the aldehyde substrate entrance tunnel. In P5CDHs, the beginning of the peptide provides critical hydrogen bonding groups that anchor the backbone of GSA, as well as a conserved Phe that packs against the aliphatic chain of GSA ( Figure  3B) . 12, 16, 18 The observation of disorder in the aldehyde anchor peptide suggests the hypothesis that in solution the anchor peptide samples conformations other than the one that binds the substrate.
Structure of the Put2p−NAD + Complex. The structure of Put2p complexed with NAD + was determined (Table 1) . Electron density for the ADP group of NAD + is strong in both protomers (Figure 4) . Density for the nicotinamide ribose is strong in one protomer and somewhat weaker in the other. Density for the nicotinamide is diffuse in both protomers, implying disorder, and thus, the nicotinamide was omitted from the final model deposited in the PDB. Disorder of the nicotinamide has been reported for ALDHs. 12, 16, 37 NAD + binds in the expected location, with the adenine ring wedged between valine and proline residues belonging to helices of the Rossmann fold domain (Figure 4 ). The adenine ribose forms hydrogen bonds with Lys234, and the pyrophosphate interacts with Ser288. The nicotinamide ribose hydrogen bonds with Glu458. These interactions are also observed in the structure of the MmP5CDH−NAD + complex. 12 Binding of the cofactor is accompanied by side chain rotations (Figure 4 ). Phe460 rotates around χ 1 by 96°to avoid a steric clash with the nicotinamide ribose. Glu458 rotates by 120°, allowing a hydrogen bond with the nicotinamide ribose. These torsional rotations have not been reported for other P5CDHs.
Structure of Monoclinic HsP5CDH. To further explore the idea that the aldehyde anchor peptide is flexible in solution, the structure of a second eukaryotic P5CDH without a ligand bound in the aldehyde site was determined. The structure of ligand-free HsP5CDH was determined from a new monoclinic crystal form ( Table 1) that was obtained only after cleaving the N-terminal His tag.
As in the Put2p structure, electron density for the aldehyde anchor peptide of monoclinic HsP5CDH (residues 514−535) is very weak ( Figure 3C ). Electron density for these residues is essentially absent in chains A and D, and the entire loop was omitted. In the other two chains in the asymmetric unit, the binding of Mg 2+ from the crystallization buffer stabilizes residues 522−535 in a non-native conformation, but the other residues of the loop remain disordered. Thus, the disordered active site is not limited to Put2p.
Oligomeric State and Quaternary Structure of Put2p. The oligomeric state of Put2p in solution was investigated using Figure 5 ). Guinier plots of data from three samples having different protein concentrations yield a radius of gyration (R g ) in the range of 47−48 Å. Calculations of the pair distribution function suggest a maximal particle dimension of 140−150 Å and an R g of 45 Å. The R g of the Put2p dimer in the asymmetric unit ( Figure 2B ) is only 31.5 Å, which suggests that a higher-order oligomer is formed in solution. Furthermore, the theoretical SAXS curve calculated from the dimer deviates substantially from the experimental curve ( Figure 5A ).
SAXS (
The Put2p crystal lattice was inspected to identify a higherorder assembly that is consistent with the SAXS data.
Application of the crystallographic 3-fold rotation to the dimer in the asymmetric unit generates a point group 32 hexamer with an R g of 43.9 Å (Figure 5B ), which is close to the experimental R g of 48 Å. The scattering profile calculated from the Put2p hexamer shows good agreement with the experimental profile ( Figure 5A ). Slightly better agreement is obtained with the hexamer of TtP5CDH (Figure 5A ), which includes the sections that are disordered in Put2p. Consideration of a mixture of hexamers and dimers using minimal ensemble search 38 did not improve the fit. The hexamer oligomeric state was confirmed by estimating the molecular mass from SAXS data using the volume of correlation (V c ) invariant. 39 The V c of Put2p is 1459 Å 2 , which corresponds to a molecular mass of 363 kDa. This value is within 4% of the expected molecular mass of 376 kDa for a hexamer of the Put2p protein used for SAXS. We concluded that the predominant form of Put2p in solution is the trimer-ofdimers hexamer observed in the crystal lattice.
Finally, shape reconstruction calculations are also consistent with the hexamer. The shape reconstruction was performed with the SASTBX server, 32 which makes no explicit assumptions about the molecular mass, the number of residues, or the oligomeric state of the particle under consideration. The envelope is consistent with the crystallographic hexamer ( Figure 5B ).
Hexamerization Hot Spot of Put2p. We previously identified a hexamerization hot spot in bacterial P5CDHs. 19 The hot spot is located in the interface between two dimers and is formed by α3 of one molecule and the oligomerization domain of another molecule ( Figure 6A ). In the bacterial P5CDH hexamers, an Arg residue of α3 (e.g., Arg100 of TtP5CDH) is at the center of the hot spot and forms several electrostatic interactions across the dimer−dimer interface ( Figure 6C ). Mutation of this Arg to Ala in TtP5CDH or DrP5CDH abrogates hexamerization in favor of dimers, showing that it is essential for hexamer formation.
Interestingly, Ala126 of Put2p replaces Arg100 of TtP5CDH, while Trp193 of Put2p replaces Asp166 of TtP5CDH of the oligomerization domain ( Figure 6B ). Trp193 occupies the space corresponding to the Arg100 side chain of TtP5CDH. The indole of Trp193 fits into a hole formed by several residues of α3 (Phe121, Tyr122, Ser125, Ala126, and Leu129) as well as Val174 of α5 ( Figure 6B ). We therefore hypothesized that Trp193 is the center of the hexamerization hot spot of Put2p, analogous to the essential Arg of Tt5CDH and DrP5CDH. This idea was tested by creating Put2p variant W193A.
The oligomeric state of W193A was determined using sedimentation velocity. Figure 7A displays a subset of the velocity profiles, with the corresponding least-squares fits. Analysis of the entire data set with SEDFIT yielded a symmetric sedimentation coefficient distribution centered at 4.65 S ( Figure 7B ). The corresponding molecular mass distribution is centered at 121 kDa ( Figure 7C ), which is within 3% of the theoretical M of the W193A dimer (125 kDa). Thus, mutation of Trp193 to Ala appears to have disrupted the hexamer, as intended.
W193A was also analyzed using SAXS (Figure 8 ). Guinier plots of data from three samples having different protein concentrations yield an R g in the range of 34.5−34.7 Å. Calculations of the pair distribution function suggest a maximal particle dimension of 110−115 Å and an R g of 34.7 Å. As stated above, the R g of the Put2p dimer in the asymmetric unit is 31.5 Å, whereas that of the hexamer is 44 Å. Thus, the R g of W193A is consistent with a dimer in solution. The theoretical SAXS curve calculated from the Put2p dimer agrees well with the experimental one, while the curve derived from the hexamer curve shows significant deviation ( Figure 8A) . Furthermore, the envelope from shape reconstruction calculations, performed with the SASTBX server, is consistent with the crystallographic dimer ( Figure 8B) . Thus, the SAXS data are also consistent with W193A being primarily dimeric in solution.
■ DISCUSSION
The disordered aldehyde anchor loop is the major result from the Put2p and HsP5CDH crystal structures reported here. It is tempting to speculate that these structures represent the resting enzyme conformation, implying that aldehyde binding stabilizes the active site. This interpretation is supported by the fact that all other structures of eukaryotic P5CDHs (human and mouse) have ligands bound in the aldehyde site, including sulfate ion from the crystallization buffer (PDB entries 3V9J and 3V9H), 12 the product glutamate (PDB entry 3V9K), 12 and proline (PDB entry 4E3X), 40 which is a competitive inhibitor with respect to GSA.
1 Although a ligand was not modeled in two other structures (PDB entries 3V9L and 3V9G), electron density consistent with an active site ligand, probably sulfate ion, is nevertheless evident. Thus, none of the previously determined structures of eukaryotic P5CDHs are truly representative of the aldehyde-free conformation. Bacterial P5CDH structures, however, provide a counterargument; a few bacterial P5CDHs have an ordered active site in the absence of a ligand in the aldehyde site (e.g., PDB entries 2EHQ, 2BHP, and 3RJL). Nevertheless, the observation that the aldehyde anchor peptide is disordered in two different P5CDHs that were crystallized in unrelated lattices suggests that the disorder may be functionally relevant, at least for eukaryotic P5CDHs. At the very least, the structures provide evidence that the aldehydebinding loop is inherently flexible, possibly sampling active and inactive conformations in the absence of the substrate. In this view, Put2p would be an example of substrate recognition by conformational selection. 41 These results add a new dimension to our understanding of ALDH substrate specificity. Disorder in enzyme active sites on the scale described here has precedent, and retinal dehydrogenase II is the most germane example. Also a member of the ALDH superfamily, retinal dehydrogenase II catalyzes the oxidation of retinal to retinoic acid and is thus involved in retinoic acid signaling. As in Put2p, the aldehyde-binding loop is disordered in the crystal structure of retinal dehydrogenase II (PDB entry 1BI9). It has been proposed that the disordered loop plays a role in discriminating retinal from smaller potential substrates. 43, 44 The discovery that Put2p is hexameric is unexpected. Put2p and HsP5CDH are eukaryotic P5CDHs that have 42% identical amino acid sequences, yet Put2p is hexameric and HsP5CDH dimeric. 12 The trimer-of-dimers hexamer described here for Put2p is also formed by TtP5CDH and DrP5CDH, 19 although Put2p is only 30% identical to these bacterial P5CDHs. Curiously, other bacterial P5CDHs, such as those from Bacillus species, are dimeric. 19 Thus, global sequence identity and domain of life are poor predictors of the oligomeric states of P5CDHs. Instead, we suggest that the hot spot theory of protein−protein association provides a better explanation. 45, 46 The Put2p structure revealed Trp193 as a potential hot spot residue. Trp193 is located in the same region as the bacterial hexamerization hot spot, where it forms nonpolar, knob-in-hole interactions across the dimer−dimer interface ( Figure 6B) . Furthermore, Trp, along with Tyr and Arg, is often found in protein−protein interface hot spots. 45 Mutation of Trp193 to Ala abrogates hexamer formation, suggesting that these nonpolar interactions ( Figure 6B ) substitute for the electrostatic interactions that stabilize the bacterial P5CDH hexamers ( Figure 6C) . Thus, the ALDH4A1 hexamerization hot spot appears to be a unique region of three-dimensional structural space that must be occupied by residues capable of forming attractive intermolecular forces for hexamerization to occur. Interestingly, the precise nature of these forces appears to be less important that than their location.
Finally, the hot spot theory provides a satisfactory explanation for why some P5CDHs are dimeric. A theoretical hexamer built from HsP5CDH dimers has vacant space in the hot spot region instead of the tight knob-in-hole interaction observed in Put2p. The result reflects the fact that the mammalian enzymes have the short residue Thr in place of Trp193. Also, hexamers built from the Bacillus P5CDH dimers show steric clashes of long side chains across the dimer−dimer interface. Thus, the dimeric enzymes do not have an appropriate constellation of residues for building a functional hexamerization hot spot. ■ ABBREVIATIONS PRODH, proline dehydrogenase; P5C, Δ 1 -pyrroline-5-carboxylate; GSA, γ-glutamate semialdehyde; P5CDH, Δ 1 -pyrroline-5- 
